Showing results (1171-1180 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|January 26, 2005
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)F J Barrero, I Ampuero, B Morales, et al.
The Pharmacogenomics Journal|January 26, 2005
Association between the DRD2 gene Taq1A (C32806T) polymorphism and alcohol consumption in social drinkersM R Munafò, E C Johnstone, K I Welsh, et al.
The Pharmacogenomics Journal|November 10, 2004
CYP2A6 genetic polymorphisms and correlation with smoking status in BraziliansG M Vasconcelos, C J Struchiner, G Suarez-Kurtz
The Pharmacogenomics Journal|October 27, 2004
Association study of myo-inositol monophosphatase 2 (IMPA2) polymorphisms with bipolar affective disorder and response to lithium treatmentA Dimitrova, V Milanova, S Krastev, et al.
The Pharmacogenomics Journal|September 29, 2004
Lower frequency of CYP2C9*2 in Mexican-Americans compared to SpaniardsA LLerena, P Dorado, F O'Kirwan, et al.
The Pharmacogenomics Journal|May 19, 2004
The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patientsY Suzuki, K Sawamura, T Someya
The Pharmacogenomics Journal|April 28, 2004
Variable drug metabolism genes in Arab populationR Bu, M I Gutiérrez, M Al-Rasheed, et al.
The Pharmacogenomics Journal|March 26, 2002
The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expressionS Fuke, S Suo, N Takahashi, et al.
The Pharmacogenomics Journal|March 27, 2002
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyS T Pullarkat, J Stoehlmacher, V Ghaderi, et al.
The Pharmacogenomics Journal|May 7, 2002
Tetanus antigen modulates the gene expression profile of aluminum phosphate adjuvant in spleen lymphocytes in vivoK Regnström, E G E Ragnarsson, N Rydell, et al.
Pageof 135